Drugs Made In America Acquisition Corp. (DMAA) stock
DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)
Close on Nov 16, 2026Market cap $264.62MP/E –Yield –
Drugs Made In America Acquisition cash
Cash and short-term investments held at the end of each period.
Drugs Made In America Acquisition's cash was $20.28K at Jun 30, 2026. For fiscal 2025 it was $6.14K, up 354.3% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.14K | +354.3% |
| FY2024 | Dec 31, 2024 | $1.35K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $20.28K | +2367.2% |
| Q1 FY2026 | Mar 31, 2026 | $14.89K | +1711.1% |
| Q4 FY2025 | Dec 31, 2025 | $6.14K | +354.3% |
| Q3 FY2025 | Sep 30, 2025 | $717 | -65.8% |
| Q2 FY2025 | Jun 30, 2025 | $822 | -95.5% |
| Q1 FY2025 | Mar 31, 2025 | $822 | – |
| Q4 FY2024 | Dec 31, 2024 | $1.35K | – |
| Q3 FY2024 | Sep 30, 2024 | $2.10K | – |
| Q2 FY2024 | Jun 30, 2024 | $18.10K | – |
See a number that looks wrong?